ACG, the Mumbai-based provider of capsules, pharma machinery and packaging materials, has announced a $200-mn phased investment to establish its first empty-capsule manufacturing operations in the US.
The initial $100-mn will fund a modern hard-shell capsule facility in Atlanta, Georgia, with a second phase of $100-mn planned to expand capacity and capabilities in the region. The investment is expected to create more than 200 jobs, with operations targeted to begin in early 2027.
“ACG has served North America for over 25 years. This facility strengthens our ties with customers across the region - bringing us closer to them, enabling faster lead times, higher-quality service, and a more resilient, de-risked supply chain. Just as importantly, it lets us respond more quickly and co-develop new innovations through tighter R&D partnerships. It’s been a long time coming, and we’re glad to say it’s here,” said Mr. Karan Singh, Managing Director, ACG.
ACG will establish dedicated facilities to manufacture gelatin and vegetarian (HPMC) hard-shell capsules. The programme complements the company’s US ecosystem spanning capsules, barrier packaging materials, processing and encapsulation machinery, visual inspection, and traceability solutions—supported by nationwide sales and service.
“Atlanta is the right location to execute at scale,” said Mr. Selwyn Noronha, CEO, ACG Capsules. “Combined with ACG’s recent facility builds in Aurangabad (HPMC), Thailand (gelatin), and expansions in Brazil, Croatia and India, we have the operating discipline to begin production quickly and deliver reliable supply for North American customers.”
ACG has operated in the United States for more than 25 years, with North American headquarters in Piscataway, New Jersey, manufacturing liquid fill capsules in Chadds Ford, Pennsylvania, with several warehouses across the US, and sales and service teams nationwide.


24 October, 2025 16:01:52 IST 
















